12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
12 health care stocks experienced significant price movements during Tuesday's pre-market session, with 6 gainers and 6 losers. Notable gainers include Black Diamond Therapeutic, Biodexa Pharmaceuticals, and CalciMedica, while Adicet Bio, Nemaura Medical, and Trxade Health were among the losers.
June 27, 2023 | 1:12 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Adicet Bio's shares fell 13.7% to $4.02 during Tuesday's pre-market session, with a market cap of $172.6 million.
Adicet Bio's shares experienced a significant decline of 13.7% during the pre-market session, indicating negative investor sentiment and potential for further decline in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Trxade Health's shares decreased by 12.9% to $14.25, with a market value of $145.5 million.
Trxade Health's shares experienced a significant decline of 12.9% during the pre-market session, indicating negative investor sentiment and potential for further decline in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Nemaura Medical's shares declined by 12.93% to $0.64, with a market cap of $18.4 million.
Nemaura Medical's shares experienced a significant decline of 12.93% during the pre-market session, indicating negative investor sentiment and potential for further decline in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Biodexa Pharmaceuticals' stock increased by 21.43% to $0.08, with a market value of $1.4 million.
Biodexa Pharmaceuticals' stock rose by 21.43% during the pre-market session, indicating increased investor interest and potential for short-term growth.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
Black Diamond Therapeutic's stock rose 125% to $4.14 during Tuesday's pre-market session, with a market cap of $151.1 million.
Black Diamond Therapeutic's stock experienced a significant increase of 125% during the pre-market session, indicating strong investor interest and potential for continued growth in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
CalciMedica's stock increased by 19.93% to $4.03, with a market cap of $22.8 million.
CalciMedica's stock experienced a significant increase of 19.93% during the pre-market session, indicating strong investor interest and potential for continued growth in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100